Director Shareholding
December 12 2002 - 6:24AM
UK Regulatory
RNS Number:0265F
Cambridge Antibody Tech Group PLC
12 December 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1. Name of company
Cambridge Antibody Technology
2) Name of director
John Aston
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in
respect of a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Allocation of partnership and matching shares under Inland Revenue Approved
Share Incentive Plan
7) Number of shares/amount of
stock acquired
610 ( consisting of 305 partnership shares and 305 matching shares)
8) Percentage of issued class
0.0017%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
N/A
11) Class of security
Ordinary 10 Pence
12) Price per share
#4.91
13) Date of transaction
11 December 2002
14) Date company informed
11 December 2002
15) Total holding following this notification
28,798
16) Total percentage holding of issued class following this notification
0.079%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01223 471471
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 12 December 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
2. Name of company
Cambridge Antibody Technology
2) Name of director
David Glover
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in
respect of a non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Allocation of partnership and matching shares under Inland Revenue Approved
Share Incentive Plan
7) Number of shares/amount of
stock acquired
610 (consisting of 305 partnership shares and 305 matching shares)
8) Percentage of issued class
0.0017%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
N/A
11) Class of security
Ordinary 10 Pence
12) Price per share
#4.91
13) Date of transaction
11 December 2002
14) Date company informed
11 December 2002
15) Total holding following this notification
11,529
16) Total percentage holding of issued class following this notification
0.032%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
None
24) Name of contact and telephone number for queries
Justin Hoskins, 01223 471471
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 12 December 2002
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAAAAFADAFFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2023 to Aug 2024